Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines

被引:0
|
作者
Foltran, D. [1 ]
Delmas, C. [2 ]
Flumian, C. [1 ]
De Paoli, P. [1 ]
Salvo, F. [3 ]
Gautier, S. [4 ]
Drici, M. [5 ]
Karsenty, C. [6 ]
Montastruc, F. [7 ]
机构
[1] Dept Med & Clin Pharmacol, Toulouse, France
[2] Dept Cardiol, Toulouse, France
[3] Med Pharmacol Unit, Bordeaux, France
[4] Dept Clin Pharmacol, Lille, France
[5] Dept Pharmacol & Pharmacovigilance, Nice, France
[6] Pediat Cardiol Unit, Toulouse, France
[7] Dept Med & Clin Pharmacol, Memphis, TN USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS-043
引用
收藏
页码:114 / 115
页数:2
相关论文
共 50 条
  • [22] MYOCARDITIS AND PERICARDITIS DIAGNOSIS TRENDS FROM 2018-2023 AND THE INFLUENCE OF COVID-19 INFECTION AND MRNA COVID-19 VACCINES
    Chapman, Scott
    Murray, Kimberly
    Hozayen, Sameh
    Margraf, David
    Neumann, Jake T.
    Leslie, Alison
    Sokos, George G.
    Patel, Brijesh D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 595 - 595
  • [23] Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination
    Oka, Akihiro
    Sudo, Yuya
    Miyoshi, Toru
    Ozaki, Masatomo
    Kimura, Yuta
    Takagi, Wataru
    Ugawa, Satoko
    Okada, Tomoaki
    Nosaka, Kazumasa
    Doi, Masayuki
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [24] Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
    Roeder, Alexa J.
    Koehler, Megan A.
    Jasbi, Paniz
    McKechnie, Davis
    Vanderhoof, John
    Edwards, Baylee A.
    Gonzalez-Moa, Maria J.
    Seit-Nebi, Alim
    Svarovsky, Sergei A.
    Lake, Douglas F.
    VACCINES, 2022, 10 (09)
  • [25] COVID-19, Myocarditis and Pericarditis
    Fairweather, DeLisa
    Beetler, Danielle J. J.
    Di Florio, Damian N. N.
    Musigk, Nicolas
    Heidecker, Bettina
    Cooper, Leslie T. T.
    CIRCULATION RESEARCH, 2023, 132 (10) : 1302 - 1319
  • [26] Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines
    Shay, David K.
    Shimabukuro, Tom T.
    DeStefano, Frank
    JAMA CARDIOLOGY, 2021, 6 (10) : 1115 - 1117
  • [27] Risk of myocarditis/pericarditis after mRNA COVID-19 vaccination in commercial insurance claims
    Secora, Alex
    Goodman, Michael
    Reich, Christian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 627 - 627
  • [28] Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
    Luk, Adriana
    Clarke, Brian
    Dahdah, Nagib
    Ducharme, Anique
    Krahn, Andrew
    McCrindle, Brian
    Mizzi, Trent
    Naus, Monika
    Udell, Jacob A.
    Virani, Sean
    Zieroth, Shelley
    McDonald, Michael
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (10) : 1629 - 1634
  • [29] Myocarditis and Pericarditis After mRNA COVID-19 Vaccination: 2024 Status and Management Update
    McDonald, Michael A.
    Kafil, Tahir S.
    Khoury, Michael
    Luk, Adriana C.
    Wright, Meredith K.
    Hawkins, Nathaniel M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2024, 40 (09) : 1536 - 1540
  • [30] Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
    Pepe, Salvatore
    Gregory, T. Ann
    Denniss, A. Robert
    HEART LUNG AND CIRCULATION, 2021, 30 (10): : 1425 - 1429